JP3495738B2
(ja)
*
|
1995-09-14 |
2004-02-09 |
ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
天然PrPsc特異的抗体
|
AU713529B2
(en)
*
|
1996-04-03 |
1999-12-02 |
Stichting Dienst Landbouwkundig Onderzoek |
Method for the detection of prion diseases
|
EP0934531B1
(de)
*
|
1996-10-15 |
2004-08-04 |
D-Gen Limited |
Diagnose spongiformer encephalopathie
|
GB2319607A
(en)
*
|
1996-11-23 |
1998-05-27 |
Electrophoretics International |
Detection of prion proteins in mononuclear cells
|
PT909388E
(pt)
*
|
1997-02-06 |
2004-01-30 |
Enfer Technology Ltd |
Ensaios imunologicos para encefalopatias espongiformes
|
US6221614B1
(en)
*
|
1997-02-21 |
2001-04-24 |
The Regents Of The University Of California |
Removal of prions from blood, plasma and other liquids
|
US20060008494A1
(en)
*
|
1997-02-21 |
2006-01-12 |
The Regents Of The University Of California |
Complete inactivation of infectious proteins
|
US6720355B2
(en)
*
|
1997-02-21 |
2004-04-13 |
The Regents Of The University Of California |
Sodium dodecyl sulfate compositions for inactivating prions
|
US6617119B2
(en)
|
1997-02-21 |
2003-09-09 |
The Regents Of The University Of California |
Assay for specific strains of multiple disease related conformations of a protein
|
EP0861900A1
(de)
*
|
1997-02-21 |
1998-09-02 |
Erziehungsdirektion Of The Canton Zurich |
Immunologischer Nachweis von Prionen
|
US6719988B2
(en)
|
1997-02-21 |
2004-04-13 |
The Regents Of The University Of California |
Antiseptic compositions for inactivating prions
|
US6620629B1
(en)
|
1997-02-21 |
2003-09-16 |
The Regents Of The University Of California |
Method for detecting prions
|
TW585921B
(en)
*
|
1997-07-10 |
2004-05-01 |
Res Dev Foundation |
Species specific monoclonal antibodies and phage displayed Fab and scFV fragments for fragments for targeted destruction of imported fire ants
|
ATE223058T1
(de)
|
1997-09-19 |
2002-09-15 |
Evotec Ag |
Verfahren zur messung der assoziation von teilstrukturen pathologischer proteinablagerungen
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US6923964B1
(en)
*
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
ATE420355T1
(de)
*
|
1997-12-16 |
2009-01-15 |
Univ Zuerich |
Diagnostik für übertragbare spongiforme enzephalopathie
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
US6528269B1
(en)
*
|
1998-06-22 |
2003-03-04 |
Case Western Reserve University |
Immunological agents specific for prion protein (PRP)
|
GB2362385B
(en)
*
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Non-aggregated ß-forms of prion proteins
|
GB2371049B
(en)
*
|
1998-11-04 |
2003-06-04 |
Imp College Innovations Ltd |
Methods of making antibodies against ß-forms of prion proteins and their uses
|
GB2348203B
(en)
*
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
FI982480A0
(fi)
*
|
1998-11-17 |
1998-11-17 |
Wallac Oy |
Immunomääritys nisäkkäiden tarttuvan spongiomuotoisen aivotaudin määrittämiseksi
|
FI982481A0
(fi)
*
|
1998-11-17 |
1998-11-17 |
Wallac Oy |
Immunomääritys nautaeläinten tarttuvan spongiomuotoisen aivotaudin määrittämiseksi
|
JP5122705B2
(ja)
*
|
1999-01-25 |
2013-01-16 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
神経変性疾患における異常型タンパク質凝集の迅速かつ高感度の検出
|
GB9902659D0
(en)
*
|
1999-02-05 |
1999-03-31 |
Microbiological Res Authority |
Assay with reduced background
|
EP1151305A1
(de)
|
1999-02-11 |
2001-11-07 |
Stichting Dienst Landbouwkundig Onderzoek |
Prion test
|
GB2346971B
(en)
*
|
1999-02-19 |
2004-07-21 |
Audrey Ann Coop |
Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
|
US6605445B1
(en)
*
|
1999-02-22 |
2003-08-12 |
Bayer Corporation |
Rapid method of determining clearance of prion protein
|
US6166187A
(en)
*
|
1999-03-05 |
2000-12-26 |
The Regents Of The University Of California |
Method of concentrating prion proteins in blood samples
|
DE19918141A1
(de)
*
|
1999-04-21 |
2000-10-26 |
Boehringer Ingelheim Vetmed |
Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
DE19925073C2
(de)
*
|
1999-06-01 |
2001-07-19 |
Stefan Weiss |
Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung
|
JP2003521477A
(ja)
*
|
1999-06-23 |
2003-07-15 |
カプリオン ファーマシューティカルズ インコーポレーティッド |
プリオン蛋白質ペプチドおよびその使用
|
US7041807B1
(en)
|
1999-06-23 |
2006-05-09 |
Caprion Pharmaceuticals, Inc. |
Antibodies to a YYX epitope of a mammalian prion protein
|
US6261790B1
(en)
*
|
1999-07-15 |
2001-07-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
|
US20040013647A1
(en)
*
|
1999-09-03 |
2004-01-22 |
Ramot At Tel-Aviv University Ltd. |
Methods and compositions for treating a plaque-forming disease
|
EP1180938B1
(de)
*
|
1999-09-03 |
2010-03-24 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Verbindungen, zusammensetzungen und verfahren zur behandlung oder vorsorge von alzheimer erkrankung
|
US20020052311A1
(en)
*
|
1999-09-03 |
2002-05-02 |
Beka Solomon |
Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
|
WO2001019867A1
(de)
*
|
1999-09-14 |
2001-03-22 |
Memorec Stoffel Gmbh |
Prionen-verwandtes protein
|
EP1216258A1
(de)
*
|
1999-09-28 |
2002-06-26 |
Universität Zürich |
Faktoren mit prionen bindender aktivität im serum und plasma sowie mittel zur bestimmung von übertragbaren spongiformen encephalopathien
|
US6437102B1
(en)
|
1999-11-24 |
2002-08-20 |
Bayer Corporation |
Method of separating prions from biological materials
|
US7098317B1
(en)
*
|
2000-05-23 |
2006-08-29 |
Blood Transfusion Center Of Slovenia |
Antibodies capable to selectively detect prion PrPSc isoforms
|
EP1158003B2
(de)
*
|
2000-05-23 |
2012-12-26 |
Blood Transfusion Centre of Slovenia |
Antikörper zum selektiven Nachweis von Prion PrP Sc Isoformen
|
US6537548B1
(en)
*
|
2000-07-27 |
2003-03-25 |
The Regents Of The University Of California |
Antibodies specific for ungulate PrP
|
US20050130320A1
(en)
*
|
2000-11-09 |
2005-06-16 |
George Shaji. T. |
Method for identifying the proteome of cells using an antibody library microarray
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
DE10061200A1
(de)
*
|
2000-12-08 |
2002-06-27 |
Niels Wedemeyer |
Verfahren und Kit zur Diagnose spongiformer Encephalopathien
|
WO2002046236A1
(fr)
*
|
2000-12-08 |
2002-06-13 |
Fujirebio Inc. |
Anticorps monoclonal dirigé contre un prion anormal, procédé de production correspondant, et procédé d'essai immunologique l'utilisant
|
US20020194635A1
(en)
*
|
2001-03-30 |
2002-12-19 |
Dunne Patrick W. |
Transgenic animals resistant to transmissible spongiform encephalopathies
|
DE10120562C2
(de)
*
|
2001-04-26 |
2003-04-10 |
Horst Messer |
Verfahren zur Diagnose von übertragbaren spongiformen Enzephalopathien
|
CA2448981C
(en)
*
|
2001-05-31 |
2014-03-18 |
Arete Associates |
Misfolded protein sensor method
|
US20050026165A1
(en)
|
2001-05-31 |
2005-02-03 |
Cindy Orser |
Detection of conformationally altered proteins and prions
|
GB0125606D0
(en)
*
|
2001-10-25 |
2001-12-19 |
Sec Dep For Environment Food & |
Diagnostic method
|
RU2309410C2
(ru)
*
|
2002-02-28 |
2007-10-27 |
Майкроусенс Байофейдж Лимитед |
Связывание патологических форм прионовых белков
|
US8658374B2
(en)
|
2002-02-28 |
2014-02-25 |
Microsens Biphage Limited |
Binding of aggregated forms of proteins
|
BR0200690A
(pt)
*
|
2002-03-04 |
2004-03-23 |
Embrapa Pesquisa Agropecuaria |
Método para detecção de proteinas de origem em misturas complexas
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
NZ536054A
(en)
*
|
2002-04-09 |
2009-10-30 |
Scripps Research Inst |
Motif-grafted hybrid polypeptides and uses thereof
|
EP1534746A2
(de)
*
|
2002-08-23 |
2005-06-01 |
Copenhagen Biotech Assets APS |
Mischpeptide zum nachweis und behandlung der von prion-proteinen verursachten krankheiten
|
AU2003272491B2
(en)
*
|
2002-09-18 |
2008-10-02 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
|
US20040072236A1
(en)
*
|
2002-09-27 |
2004-04-15 |
Neil Cashman |
PrPSc -interacting molecules and uses thereof
|
US20040067496A1
(en)
*
|
2002-10-07 |
2004-04-08 |
Robert Pytela |
System for production and screening of monoclonal antibodies
|
DE03799419T1
(de)
*
|
2002-10-10 |
2005-04-07 |
The Regents Of The University Of California, Oakland |
Verwendung monoklonaler antikörper zur unterscheidung von proteinkonformationsisoformen
|
US20040175775A1
(en)
*
|
2002-11-08 |
2004-09-09 |
Neil Cashman |
Method of detecting PrPsc in eye fluid
|
GB0227886D0
(en)
*
|
2002-11-29 |
2003-01-08 |
Medical Res Council |
Prion inhibition
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
WO2005019412A2
(en)
|
2003-05-20 |
2005-03-03 |
New York University |
Mucosal immunization to prevent prion infection
|
US8685718B2
(en)
*
|
2003-05-20 |
2014-04-01 |
New York University |
Mucosal immunization to prevent prion infection
|
TWI374893B
(en)
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US20060035242A1
(en)
*
|
2004-08-13 |
2006-02-16 |
Michelitsch Melissa D |
Prion-specific peptide reagents
|
NZ580256A
(en)
*
|
2003-08-13 |
2011-07-29 |
Novartis Vaccines & Diagnostic |
Prion-specific peptide reagents comprising the sequence KKRPKPGG
|
WO2005034995A1
(en)
*
|
2003-09-10 |
2005-04-21 |
Chiron Corporation |
Prion chimeras and uses thereof
|
TWI333977B
(en)
*
|
2003-09-18 |
2010-12-01 |
Symphogen As |
Method for linking sequences of interest
|
WO2005111609A2
(en)
*
|
2004-04-19 |
2005-11-24 |
Department Of Veterans Affairs |
Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
|
US20060057671A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Orser Cindy S |
Immobilized probes and methods of detecting conformationally altered prion proteins
|
JP4644680B2
(ja)
*
|
2004-10-15 |
2011-03-02 |
積水化学工業株式会社 |
動物の免疫方法、免疫用組成物、抗体の製造方法、ハイブリドーマの製造方法、及びモノクローナル抗体の製造方法
|
WO2006046344A1
(ja)
*
|
2004-10-29 |
2006-05-04 |
Kagoshima University |
ヒト抗プリオン抗体及び該抗体フラグメント
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
PE20061401A1
(es)
*
|
2004-12-15 |
2006-12-23 |
Neuralab Ltd |
ANTICUERPOS Aß PARA MEJORAR LA COGNICION
|
US20080254486A1
(en)
*
|
2004-12-15 |
2008-10-16 |
University Of Guelph |
Prion Sensors for Diagnosis of Transmissible Spongiform Encephalopathy or for Detection of Prions, and Use Thereof
|
TW200635607A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized Aβ antibodies for use in improving cognition
|
WO2006076683A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Vaccines And Diagnostics Inc. |
Isolation and detection of pathogenic prions
|
MX2007008497A
(es)
*
|
2005-01-13 |
2007-09-14 |
Novartis Vaccines & Diagnostic |
Ensayos inmunosorbentes enlazados a enzimas usando reactivos de peptidos especificos de prion.
|
US20090099343A1
(en)
*
|
2005-01-13 |
2009-04-16 |
David Peretz |
Isolation of pathogenic prions
|
US8372593B2
(en)
|
2005-02-15 |
2013-02-12 |
Adlyfe, Inc. |
Method for detecting misfolded proteins and prions
|
WO2006105622A1
(fr)
*
|
2005-04-04 |
2006-10-12 |
Universite De Liege |
Nouveaux supports, en particulier pour 1 ' immunodetection molecules d'interet
|
US20090209867A1
(en)
*
|
2005-04-18 |
2009-08-20 |
Cha Min Tang |
Method for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
|
EP1931695B1
(de)
*
|
2005-09-09 |
2013-04-10 |
Novartis AG |
Prionspezifische Peptoidreagentien
|
KR101439828B1
(ko)
|
2005-11-30 |
2014-09-17 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
AU2006319358B2
(en)
|
2005-11-30 |
2012-01-19 |
AbbVie Deutschland GmbH & Co. KG |
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
US8876753B2
(en)
|
2006-01-30 |
2014-11-04 |
The Regents Of The University Of California |
Peritoneal dialysis methods and apparatus
|
US8187250B2
(en)
*
|
2006-01-30 |
2012-05-29 |
The Regents Of The University Of California |
Peritoneal dialysis methods and apparatus
|
US20070196863A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Hanson Technologies, Inc. |
Prion protein detection
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
KR101605207B1
(ko)
|
2006-07-14 |
2016-03-22 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
US20080131500A1
(en)
*
|
2006-12-04 |
2008-06-05 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for rapid inactivation of proteins
|
WO2008104386A2
(en)
|
2007-02-27 |
2008-09-04 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
RU2523894C2
(ru)
*
|
2007-04-18 |
2014-07-27 |
Янссен Альцгеймер Иммунотерапи |
Предупреждение и лечение церебральной амилоидной ангиопатии
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
BRPI0812484A2
(pt)
*
|
2007-06-12 |
2018-06-05 |
Ac Immune Sa |
anticorpo monoclonal, regiões variáveis de cadeia leve e de cadeia pesada, cdr isolada, polinucleotídeo, composição terapêutica, métodos para tratar doenças e distúrbios, para produzir um anticorpo, para tratar ou aliviar os efeitos de doenças e distúrbios, para reduzir a carga de placas no cérebro de um indivíduo, para reduzir a quantidade de placas no cérebro de um indivíduo, para diminuir a quantidade total de abeta solúvel no cérebro de um indivíduo, para reter ou aumentar a capacidade de memória cognitiva em um indivíduo, de diagnose de ou para diagnosticar uma predisposição para uma doença associada com amilóide ou condição em um paciente, para determinar a extensão de carga de placa amiloidogênica em um tecido de um indivíduo, para monitorar doença residual mínima em um indivíduo e para prever responsividade de um indivíduo, linhagem de células, kit de teste, epítopo abeta
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
EP2238166B1
(de)
|
2007-10-05 |
2013-11-27 |
Genentech, Inc. |
Verwendung eines anti-amyloid-beta-antikörpers bei augenkrankheiten
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
BRPI0910550A2
(pt)
*
|
2008-04-30 |
2015-09-29 |
Novartis Ag |
ensaio para confôrmeros patogênicos
|
CA2735020A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Symphogen A/S |
Method for cloning avian-derived antibodies
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
US9079942B2
(en)
|
2009-02-09 |
2015-07-14 |
Epitomics, Inc. |
CDR-anchored amplification method
|
US20100317539A1
(en)
*
|
2009-06-12 |
2010-12-16 |
Guo-Liang Yu |
Library of Engineered-Antibody Producing Cells
|
KR101149402B1
(ko)
*
|
2009-07-23 |
2012-06-27 |
대한민국 |
소해면상뇌증의 변형프리온을 감별 및 검출할 수 있는 단클론항체, 이를 생산하는 융합세포주 및 그 용도
|
US8293483B2
(en)
|
2009-09-11 |
2012-10-23 |
Epitomics, Inc. |
Method for identifying lineage-related antibodies
|
CA2796339C
(en)
|
2010-04-15 |
2020-03-31 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
SG187173A1
(en)
|
2010-07-30 |
2013-02-28 |
Ac Immune Sa |
Safe and functional humanized anti beta-amyloid antibody
|
EP3533803B1
(de)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antikörper
|
WO2013009767A2
(en)
|
2011-07-12 |
2013-01-17 |
Epitomics, Inc. |
Facs-based method for obtaining an antibody sequence
|